| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Aardvark Therapeutics, Inc.
13G
AARD · 002942100
|
13.7% |
5/15/2025
Event 3/31/2025
|
||||
| Tien-Li Lee | 13.7% | |||||
| Jane Wu Lee | 13.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.